Zenotech Laboratories Limited (BOM:532039)
India
· Delayed Price · Currency is INR 45.43
-1.27 (-2.72%)
At close: Apr 28, 2026
Zenotech Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 418.1 | 389.76 | 367.62 | 383.53 | 324.94 | 193.73 | Upgrade
|
| Other Revenue | 1.23 | 1.23 | 0.47 | 6.56 | 4.53 | 0.63 | Upgrade
|
| Revenue | 419.33 | 390.98 | 368.09 | 390.09 | 329.47 | 194.36 | Upgrade
|
| Revenue Growth (YoY) | 16.48% | 6.22% | -5.64% | 18.40% | 69.51% | -25.07% | Upgrade
|
| Cost of Revenue | 39.11 | 43.24 | 30.89 | 29.34 | 30.48 | 14.76 | Upgrade
|
| Gross Profit | 380.22 | 347.75 | 337.2 | 360.75 | 298.98 | 179.61 | Upgrade
|
| Selling, General & Admin | 146.16 | 124 | 94.82 | 78.99 | 71.18 | 65.12 | Upgrade
|
| Other Operating Expenses | 97.8 | 80.55 | 69.29 | 68.15 | 48.64 | 50.06 | Upgrade
|
| Operating Expenses | 314.78 | 274.14 | 234.97 | 218.87 | 189.56 | 179.74 | Upgrade
|
| Operating Income | 65.44 | 73.61 | 102.23 | 141.88 | 109.43 | -0.13 | Upgrade
|
| Interest Expense | - | - | - | -1.12 | -12.15 | -15.48 | Upgrade
|
| Interest & Investment Income | 14.09 | 14.09 | 9.45 | 3.69 | 0.99 | 0.55 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.18 | -0.18 | 0.05 | -0.01 | -0.03 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 6.57 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 85.92 | 87.52 | 111.74 | 144.44 | 98.23 | -15.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.44 | 0.39 | - | - | Upgrade
|
| Other Unusual Items | -2.81 | 19.4 | 0.12 | 0.2 | 0.78 | 2.91 | Upgrade
|
| Pretax Income | 83.11 | 106.92 | 111.41 | 145.02 | 99.01 | -12.15 | Upgrade
|
| Income Tax Expense | 49.5 | 50.79 | 28.43 | 29.17 | -122.75 | - | Upgrade
|
| Net Income | 33.62 | 56.13 | 82.99 | 115.85 | 221.76 | -12.15 | Upgrade
|
| Net Income to Common | 33.62 | 56.13 | 82.99 | 115.85 | 221.76 | -12.15 | Upgrade
|
| Net Income Growth | -32.62% | -32.36% | -28.37% | -47.76% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 61 | 61 | 61 | 61 | 61 | 61 | Upgrade
|
| Shares Outstanding (Diluted) | 61 | 61 | 61 | 61 | 61 | 61 | Upgrade
|
| Shares Change (YoY) | 0.35% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.55 | 0.92 | 1.36 | 1.90 | 3.63 | -0.20 | Upgrade
|
| EPS (Diluted) | 0.55 | 0.92 | 1.36 | 1.90 | 3.63 | -0.20 | Upgrade
|
| EPS Growth | -32.86% | -32.36% | -28.37% | -47.71% | - | - | Upgrade
|
| Free Cash Flow | - | 56.25 | 75.89 | 144.33 | 157.3 | 8.3 | Upgrade
|
| Free Cash Flow Per Share | - | 0.92 | 1.24 | 2.37 | 2.58 | 0.14 | Upgrade
|
| Gross Margin | 90.67% | 88.94% | 91.61% | 92.48% | 90.75% | 92.41% | Upgrade
|
| Operating Margin | 15.61% | 18.83% | 27.77% | 36.37% | 33.21% | -0.07% | Upgrade
|
| Profit Margin | 8.02% | 14.36% | 22.55% | 29.70% | 67.31% | -6.25% | Upgrade
|
| Free Cash Flow Margin | - | 14.39% | 20.62% | 37.00% | 47.74% | 4.27% | Upgrade
|
| EBITDA | 134.1 | 143.21 | 173.08 | 213.61 | 179.16 | 64.43 | Upgrade
|
| EBITDA Margin | 31.98% | 36.63% | 47.02% | 54.76% | 54.38% | 33.15% | Upgrade
|
| D&A For EBITDA | 68.66 | 69.6 | 70.85 | 71.73 | 69.74 | 64.56 | Upgrade
|
| EBIT | 65.44 | 73.61 | 102.23 | 141.88 | 109.43 | -0.13 | Upgrade
|
| EBIT Margin | 15.61% | 18.83% | 27.77% | 36.37% | 33.21% | -0.07% | Upgrade
|
| Effective Tax Rate | 59.55% | 47.50% | 25.52% | 20.11% | - | - | Upgrade
|
| Revenue as Reported | 480.7 | 445.96 | 418.37 | 435.08 | 371.94 | 228.54 | Upgrade
|
| Advertising Expenses | - | 0.22 | 0.18 | 0.23 | 0.23 | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.